Literature DB >> 5808010

Severe depressive mood changes following slow-release intramuscular fluphenazine injection.

R De Alarcon, M W Carney.   

Abstract

Sixteen patients in whom schizophrenia was initially diagnosed and who were treated with fluphenazine enanthate or decanoate developed severe depression for a short period after the injection. In five cases this depression is thought to have been responsible for suicide. In 8 out of 10 cases the depression responded to electroplexy (E.C.T.). It is recommended that patients who are treated with fluphenazine should be carefully supervised.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5808010      PMCID: PMC1984352          DOI: 10.1136/bmj.3.5670.564

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  Psychotic depression and age.

Authors:  G A FOULDS
Journal:  J Ment Sci       Date:  1960-10

2.  A short scale for rating activity-withdrawal in schizophrenics.

Authors:  P H VENABLES
Journal:  J Ment Sci       Date:  1957-01

3.  Insulin and chlorpromazine in schizophrenia: a ten year comparative survey.

Authors:  M Markowe; J Steinert; F Heyworth-Davis
Journal:  Br J Psychiatry       Date:  1967-10       Impact factor: 9.319

  3 in total
  16 in total

1.  A comparative trial of the decanoates of flupenthixol and fluphenazine.

Authors:  M Hamilton; I R Card; G G Wallis; M R Mahmoud
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

Review 2.  Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

Review 3.  Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04       Impact factor: 5.270

4.  GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats.

Authors:  Ajaykumar N Sharma; Sagar S Ligade; Jay N Sharma; Praveen Shukla; Khalid M Elased; James B Lucot
Journal:  Metab Brain Dis       Date:  2014-07-15       Impact factor: 3.584

Review 5.  Assessment and intervention for the suicidal patient with schizophrenia.

Authors:  J M Harkavy-Friedman; E A Nelson
Journal:  Psychiatr Q       Date:  1997

6.  Effects of thymoleptics on behaviour associated with changes in brain dopamine. I. Potentiation of dopa-induced gnawing of mice.

Authors:  L Molander; A Randrup
Journal:  Psychopharmacologia       Date:  1976-02-02

Review 7.  Drugs and depression.

Authors:  F A Whitlock; L E Evans
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

8.  Treatment of chronic schizophrenia.

Authors:  D A Johnson
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

9.  The treatment of chronic pain with psychotropic drugs.

Authors:  H Merskey; R A Hester
Journal:  Postgrad Med J       Date:  1972-10       Impact factor: 2.401

10.  The correlates of the syndrome of depression in schizophrenia.

Authors:  A Tharyan; K Kuruvilla
Journal:  Indian J Psychiatry       Date:  1994-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.